PCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher
Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- "PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place Forecasting and Analysis" has been added to ResearchAndMarkets.com's offering.
The pandemic accelerated the adoption of polymerase chain reaction technology and established PCR as a central component of modern disease diagnosis. As healthcare systems move beyond pandemic-driven demand, emerging applications, evolving testing models and new molecular diagnostic technologies are reshaping the global PCR market. A comprehensive new market research report examines this transition, highlighting the commercial opportunities, competitive threats and technology trends expected to influence the industry over the next five years.
The report provides detailed PCR market forecasts designed to support strategic planning, investment analysis and company valuations. Its analysis separates the Singleplex and Multiplex testing markets, enabling decision-makers to assess the different growth patterns, demand drivers and commercial potential associated with each segment. This focused approach delivers actionable market intelligence for diagnostic companies, laboratory service providers, healthcare organizations, investors and other industry stakeholders.
PCR has demonstrated its clinical and commercial value across infectious disease testing and a growing range of molecular diagnostic applications. The next generation of the technology, digital PCR, is expected to extend that value through greater analytical precision and expanding use in areas requiring sensitive and accurate measurement. The report evaluates how digital PCR could affect market growth, product development, testing workflows and competition among established suppliers and emerging companies.
The research also examines the convergence of two major healthcare trends: Point of Care Testing and Molecular Diagnostics. Bringing molecular testing closer to patients has the potential to shorten turnaround times, support faster clinical decisions and broaden access to advanced diagnostic capabilities. The report considers how this convergence may influence instrument design, test menus, laboratory operations, decentralized testing strategies and future demand for PCR products and services.
In addition, the analysis explores the role of PCR in lowering testing costs, improving patient outcomes and supporting efforts to address Anti Microbial Resistance. Rapid and accurate molecular testing can help healthcare professionals identify relevant pathogens and make more informed treatment decisions. This creates opportunities for PCR technology providers while placing greater emphasis on performance, affordability, usability and integration within clinical settings.
Key areas covered in the report include:
Developed for organizations seeking a clearer understanding of the evolving PCR diagnostics landscape, the report brings together current market data, forward-looking forecasts and analysis of the forces shaping adoption. It enables readers to evaluate market potential, identify priority segments and compare opportunities across technologies and testing formats.
By presenting the latest evidence in a structured commercial framework, the research helps industry professionals build informed strategies and communicate market insights with confidence. Whether assessing an investment, valuing a business, planning product development or reviewing expansion opportunities, decision-makers can use the report to navigate the next phase of the global PCR market.
Key Topics Covered:
1 Market Guides
1.1 Situation Analysis
1.2 Guide for Executives and Marketing Staff
1.3 Guide for Investment Analysts and Management Consultants
2 Introduction and Market Definition
2.1 What are PCR Technologies?
2.2 PCR and Syndromic Testing
2.3 Market Definition
2.3.1 Market Size
2.3.2 Currency
2.3.3 Years
2.4 Methodology
2.4.1 Sources
2.4.2 Authors
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics
3 PCR - Guide to PCR Technologies
3.1 Concepts
3.1.1 Method
3.2 Applications
3.2.1 Finding Specific DNA
3.2.2 Measuring DNA
3.2.3 Medical and Diagnostic Applications
3.2.3.1 Carrier, prenatal and tissue typing
3.2.3.2 Cancer Diagnosis and Management
3.2.3.3 Infectious Disease - New Levels of Accuracy and Sensitivity
3.2.3.4 Forensic Applications
3.2.3.5 Science and Research
3.3 PCR - Advantages and Disadvantages
3.4 Different Types of PCR
3.4.1 Simple Changes
3.4.1.1 Multiplex-PCR
3.4.1.2 VNTR PCR
3.4.1.3 Asymmetric PCR
3.4.1.4 Long PCR
3.4.1.5 Nested PCR
3.4.1.6 Quantitative PCR
3.4.1.7 Hot-start PCR
3.4.1.8 Touchdown PCR
3.4.1.9 Assembly PCR
3.4.1.10 Colony PCR
3.4.1.11 Suicide PCR
3.4.1.12 Cold PCR
3.4.2 Digital PCR
3.4.2.1 Droplet Digital PCR
3.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)
3.4.2.3 Digital PCR in Use
3.4.2.4 Digital PCR Commercial History
3.4.3 Isothermal PCR
4 Industry Overview
4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Instrumentation Supplier
4.1.4 Chemical/Reagent Supplier
4.1.5 Pathology Supplier
4.1.6 Independent Clinical Laboratory
4.1.7 Public National/regional Laboratory
4.1.8 Hospital Laboratory
4.1.9 Physicians Office Lab (POLS)
4.1.10 Audit Body
4.1.11 Certification Body
5 Market Trends
5.1 Factors Driving Growth
5.1.1 A New Standard
5.1.2 Down the Curve We Go
5.1.3 Multiplexing
5.1.4 Syndromic Diagnostics Looks Unstoppable
5.1.5 The Genetic Blizzard
5.2 Factors Limiting Growth
5.2.1 The Cost Curve
5.2.2 The Other Guys
5.2.3 Systemic Roadblocks
5.3 Diagnostic Technology Development
5.3.1 The Instrumentation Curve
5.3.2 Shifting Role of Diagnostics
5.3.3 Diagnostics Moves Out of the Hospital
5.3.4 Disruption Looms
5.3.5 The Next Five Years
6 PCR Recent Developments
6.1 Recent Developments - Importance and How to Use This Section
6.1.1 Importance of These Developments
6.1.2 How to Use This Section
6.2 Seegene, Microsoft Collaborate for MDx Development
6.3 QuidelOrtho Expanding Savanna Test Menu
6.4 Binx Health Refocuses on POC STI Testing
6.5 Qiagen, Myriad Genetics Partner to Develop Cancer Dx
6.6 VedaBio Detecting Nucleic Acid With CRISPR
6.7 Evvy Launches Add-on STI Screen
6.8 ChromaCode Shifts to Oncology with dPCR Lung Cancer Test
6.9 Multiplex Meningitis/Encephalitis Panel Market Expanding
6.10 Sensible Dx to Launch 10-Minute POC PCR System
6.11 ReadyGo Dx Plans to Make MDx Testing Easy
6.12 Transformative Biotech Acquires Summit Biolabs' PCR Tech
6.13 Visby Medical POC STI Multiplex Test Cleared
6.14 Sherlock Biosciences Buys Sense Biodetection
6.15 Agilent, Qiagen Nab FDA Approvals for Lung Cancer Treatment CDx
6.16 HealthTrackRx Investing in Rapid Turnaround Times
6.17 LEX Dx Developing Ultra-Fast Low-Cost PCR
6.18 Next-Gen Dx Technologies Face Uncertain Future
6.19 Rover Dx Developing All-Optical Rapid POC qPCR Platform
6.20 ProtonDx Plans Rapid Molecular Dx Instrument
6.21 Innova Medical Group Licenses MDx Tech
6.22 MicroGEM to Grow Market for 30-Minute RT-PCR System
6.23 Precipio Receives CE-IVD Mark for Cancer Panels
6.24 Siemens Healthineers to Develop Next-Gen MDx Platform
6.25 New York State Approves Enzo Biochem HPV Molecular Test
6.26 Grip Molecular Developing Biosensor Panel to Detect Respiratory Infections
6.27 Co-Diagnostics Seeks EUA for At-Home PCR Diagnostic System
6.28 Chelex-Based Protocol to Reduce Cost, Time for PCR Testing
6.29 Finnish Firms to Form Point-of-Care Testing Firm
6.30 Visby Medical Scales Up Handheld PCR Test for STIs
6.31 DnaNudge Raises $60M
6.32 Roche Reports Diagnostics Revenue Up 51 Percent
6.33 BforCure Preparing Multiple ID Panels for PoC qPCR Platform
6.34 Enzo Biochem, CLX Health Partner for C19 Testing for Travel
6.35 Bio Molecular Systems Gets Approval for Portable PCR Cycler
6.36 Roche Acquires GenMark
6.37 Handheld qPCR Devices Close to Commercialization
6.38 Nuclein Closes $14M in Funding
6.39 WuXi Diagnostics Closes $150M Series B Financing Round
6.40 Visby Medical to develop rapid Flu-COVID PCR test
6.41 Thermo Fisher to Acquire Mesa Biotech
7 Profiles of Key PCR Companies
7.1 Abbott Laboratories
7.2 Accelerate Diagnostics
7.3 Ador Diagnostics
7.4 ADT Biotech
7.5 Agilent
7.6 Akonni Biosystems
7.7 Altona Diagnostics
7.8 Alveo Technologies
7.9 Amoy Diagnostics Co., Ltd.
7.10 Anatolia Geneworks
7.11 Applied BioCode
7.12 Applied DNA Sciences
7.13 Aurora Biomed
7.14 Aus Diagnostics
7.15 AVIVA Systems Biology
7.16 Beckman Coulter Diagnostics (Danaher)
7.17 Becton, Dickinson and Company
7.18 Binx Health
7.19 Biocartis
7.20 bioMerieux Diagnostics
7.21 Bioneer Corporation
7.22 Bio-Rad Laboratories, Inc
7.23 Bosch Healthcare Solutions GmbH
7.24 Bruker
7.25 Caris Molecular Diagnostics
7.26 Cepheid (Danaher)
7.27 Credo Diagnostics Biomedical
7.28 CTK Biotech
7.29 Cue Health
7.30 Curetis (OpGen)
7.31 Diagenode Diagnostics (Hologic)
7.32 Diasorin S.p.A.
7.33 Eiken Chemical
7.34 Enzo Biochem
7.35 Eurofins Scientific
7.36 Fluxergy
7.37 Fujirebio
7.38 Genetic Signatures
7.39 GenMark Dx (Roche)
7.40 Greiner Bio-One
7.41 Hologic
7.42 Immunexpress
7.43 Inflammatix
7.44 Invetech
7.45 J&J Innovative Medicine
7.46 Karius
7.47 LumiraDx
7.48 Maxim Biomedical
7.49 Meridian Bioscience
7.50 Millipore Sigma
7.51 Molbio Diagnostics
7.52 Nanomix
7.53 NGeneBio
7.54 Novacyt
7.55 Nuclein
7.56 Operon
7.57 Panagene
7.58 Precipio
7.59 Primerdesign (Novacyt)
7.60 Promega
7.61 Prominex
7.62 Qiagen
7.63 QuantuMDx
7.64 QuidelOrtho
7.65 Randox Toxicology
7.66 R-Biopharm AG
7.67 Revvity
7.68 Roche Diagnostics
7.69 Scope Fluidics
7.70 SD Biosensor
7.71 Seegene
7.72 Siemens Healthineers
7.73 SkylineDx
7.74 Sona Nanotech
7.75 SpeeDx
7.76 Standard BioTools
7.77 Stilla Technologies
7.78 Streamline Scientific
7.79 T2 Biosystems
7.80 Thermo Fisher Scientific
7.81 Uniogen
7.82 Vela Diagnostics
7.83 Veramarx
7.84 Veredus Laboratories
7.85 Vircell
7.86 Visby Medical
7.87 XCR Diagnostics
7.88 YD Diagnostics
7.89 Zhejiang Orient Gene Biotech
8 The Global PCR Markets
8.1 PCR - Global Market Overview by Country
8.1.1 Table - Global Market by Country
8.1.2 Chart - Global Market by Country
8.2 Global Market by Application - Overview
8.2.1 Table - Global Market by Application
8.2.2 Chart - Global Market by Application - Segments Growth
8.2.3 Chart - Global Market by Application - Base/Final Comparison
8.2.4 Chart - Global Market by Application - Base Year
8.2.5 Chart - Global Market by Application - Final Year
8.2.6 Chart - Global Market by Application - Share by Year
8.3 Global Market by Technology - Overview
8.3.1 Table - Global Market by Technology
8.3.2 Chart - Global Market by Technology - Segments Growth
8.3.3 Chart - Global Market by Technology - Base/Final Comparison
8.3.4 Chart - Global Market by Technology - Base Year
8.3.5 Chart - Global Market by Technology - Final Year
8.3.6 Chart - Global Market by Technology - Share by Year
8.4 Global Market by Product - Overview
8.4.1 Table - Global Market by Product
8.4.2 Chart - Global Market by Product - Segments Growth
8.4.3 Chart - Global Market by Product - Base/Final Comparison
8.4.4 Chart - Global Market by Product - Base Year
8.4.5 Chart - Global Market by Product - Final Year
8.4.6 Chart - Global Market by Product - Share by Year
8.5 Global Market by Place - Overview
8.5.1 Table - Global Market by Place
8.5.2 Chart - Global Market by Place - Segments Growth
8.5.3 Chart - Global Market by Place - Base/Final Comparison
8.5.4 Chart - Global Market by Place - Base Year
8.5.5 Chart - Global Market by Place - Final Year
8.5.6 Chart - Global Market by Place - Share by Year
9 Global PCR Markets - By Application
9.1 PCR Clinical Multiplex
9.1.1 Table PCR Clinical Multiplex Testing - by Country
9.1.2 Chart - PCR Clinical Multiplex Testing Growth
9.2 PCR Clinical Singleplex
9.2.1 Table PCR Clinical Singleplex Testing - by Country
9.2.2 Chart - PCR Clinical Singleplex Testing Growth
9.3 PCR Research
9.3.1 Table PCR Research - by Country
9.3.2 Chart - PCR Research Growth
9.4 PCR Other Application
9.4.1 Table PCR Other Application - by Country
9.4.2 Chart - Other Application Growth
10 Global PCR Markets - By Technology
10.1 qPCR
10.1.1 Table qPCR - by Country
10.1.2 Chart - qPCR Growth
10.2 dPCR
10.2.1 Table dPCR - by Country
10.2.2 Chart - dPCR Growth
10.3 Other Technology
10.3.1 Table Other Technology - by Country
10.3.2 Chart - Other Technology Growth
11 Global PCR Markets - By Product
11.1 PCR Instruments
11.1.1 Table PCR Instruments - by Country
11.1.2 Chart - PCR Instruments Growth
11.2 PCR Nucleic Acid Extraction
11.2.1 Table PCR Nucleic Acid Extraction - by Country
11.2.2 Chart - PCR Nucleic Acid Extraction Growth
11.3 PCR Consumables
11.3.1 Table PCR Consumables - by Country
11.3.2 Chart - PCR Consumables Growth
11.4 PCR Services
11.4.1 Table Services - by Country
11.4.2 Chart - PCR Services Growth
12 Global PCR Markets - By Place
12.1 PCR Clinical Laboratory
12.1.1 Table PCR Clinical Laboratory - by Country
12.1.2 Chart - PCR Clinical Laboratory Growth
12.2 PCR Point of Care
12.2.1 Table PCR Point of Care - by Country
12.2.2 Chart - PCR Point of Care Growth
12.3 PCR Commercial
12.3.1 Table PCR Commercial - by Country
12.3.2 Chart - PCR Commercial Growth
12.4 PCR Pharmaceutical
12.4.1 Table PCR Pharmaceutical - by Country
12.4.2 Chart - PCR Pharmaceutical Growth
12.5 PCR Other Place
12.5.1 Table PCR Other Place - by Country
12.5.2 Chart - PCR Other Place Growth
13 Appendices
13.1 Growth of Approved IVD Test Menu
13.2 Growth of Approved Average IVD Test Fee
13.3 The Most Used IVD Assays
13.4 The Highest Grossing Assays
13.5 Laboratory Fees Schedule
List of Tables [26]
List of Figures [47]
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/1vh00l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.